Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.3.5.1 (
succinate dehydrogenase
)
8,177
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Adult male rats exposed to tetrahydrofuran vapour at 8.2 (200 p.p.m.), 41 (1,000 p.p.m.) or 82 mumol/l (2,000 p.p.m.) for 2 to 18 weeks, five days a week, 6 hrs daily, showed dose-dependent brain and perirenal fat solvent burden linearly correlated to each other. After two weeks of exposure, the body burden of tetrahydrofuran seems to decrease. This might have been caused by increased oxidative metabolism as enhanced 7-ethoxycoumarin O-deethylase activity was detected in liver and kidneys in the 2nd week and onwards. The exposure also caused inhibition of alcohol and
formaldehyde dehydrogenase
activities in liver at the highest dose. Biochemical effects in the cerebellum were not detected while gluteal muscle specimens showed increased
succinate dehydrogenase
activity in a dose-related manner. This points to effects on the energy metabolism. Muscle acetylcholine esterase activity was also increased showing possible effects on the myoneural junctions.
...
PMID:Burden and biochemical effects of extended tetrahydrofuran vapour inhalation of three concentration levels. 660 23